Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction

Published:2019-05 Issue:19 Volume:73 Page:2365-2383
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Greene Stephen J.,Fonarow Gregg C.,DeVore Adam D.,Sharma Puza P.,Vaduganathan Muthiah,Albert Nancy M.,Duffy Carol I.,Hill C. Larry,McCague Kevin,Patterson J. Herbert,Spertus John A.,Thomas Laine,Williams Fredonia B.,Hernandez Adrian F.,Butler Javed

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Yancy;J Am Coll Cardiol,2013

2. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

3. 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction

4. Medical therapy for heart failure with reduced ejection fraction: The CHAMP-HF Registry;Greene;J Am Coll Cardiol,2018

5. Target doses of heart failure medical therapy and blood pressure: insights from the CHAMP-HF Registry;Peri-Okonny;J Am Coll Cardiol HF,2019

Cited by 369 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study;International Journal of Cardiology;2024-12

2. Clinical and economic analysis of the use of dapagliflozin in patients with chronic heart failure with reduced left ventricular ejection fraction in various subgroups of standard therapy in the Russian Federation;Terapevticheskii arkhiv;2024-09-14

3. Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry;European Journal of Heart Failure;2024-09-10

4. Association of Supranormal Left Ventricular Function With Major Adverse Cardiovascular Events: A Systematic Review of Literature;Cardiology in Review;2024-09-05

5. Protocol-driven approach to guideline-directed medical therapy optimization for heart failure: A real-world application to recovery;American Heart Journal Plus: Cardiology Research and Practice;2024-09